05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
Four years after the European Commission (“EC”) thwarted Hutchison’s attempt to consolidate the U...
Read More >
We continue to see an uptick in union petition filing and the win rate for unions in certification e...
Read More >
It is fairly easy for a plaintiff to get conditional certification in a FLSA class action case, but ...
Read More >
Bank Failed to Accommodate Manager With Pregnancy-Related Disability, Federal Agency Charged - BAL...
Read More >
As businesses in the real estate industry grapple with the fallout of the coronavirus pandemic, disp...
Read More >
Candid conversations, unfiltered insights, and a dose of hard-earned wisdom from influential women, ...
Read More >